Anti-Neuregulin-CRD (Cysteine-Rich Domain, Type III) Antibody (N126B/31)

Our Anti-Neuregulin-CRD (Cysteine-rich domain, Type III) mouse monoclonal primary antibody from NeuroMab is produced in-house from hybridoma clone N126B/31. It detects human and rat Neuregulin-CRD (Cysteine-rich domain, Type III), and is purified by Protein A chromatography. It is great for use in ICC, WB.



SKU: 75-226

Volume: 100 µL
1-2 business days
Price:
Sale price$319.00

Product Specific References for Applications and Species

Immunohistochemistry: Human
PMID Dilution Publication
24229388not listedSong, F., et al. 2014. Activation of microglial neuregulin1 signaling in the corticospinal tracts of ALS patients with upper motor neuron signs.. Amyotroph Lateral Scler Frontotemporal Degener., 77-83.
222494571:100Song, F., et al. 2012. Aberrant neuregulin 1 signaling in amyotrophic lateral sclerosis. Journal of Neuropathology and Experimental Neurology, 104-115.
Immunohistochemistry: Mouse
PMID Dilution Publication
222494571:100Song, F., et al. 2012. Aberrant neuregulin 1 signaling in amyotrophic lateral sclerosis. Journal of Neuropathology and Experimental Neurology, 104-115.
Western Blot: Human
PMID Dilution Publication
22249266not listedZhang, K., et al. 2012. A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.. Oncogene, 4609-4618.
Additional Publications: Unspecified
PMID Publication
25429153Venkatesan, K., et al. 2014. Fast-onset long-term open-state block of sodium channels by A-type FHFs mediates classical spike accommodation in hippocampal pyramidal neurons.. Journal of Neuroscience, 16126-16139.

Bulk Order Anti-Neuregulin-CRD (Cysteine-Rich Domain, Type III) Antibody

Related Products

Recently Viewed